Smith+Nephew gives Negative Pressure Wound Therapy an edge

Medical technology company, Smith+Nephew, has announced the US launch of RENASYS EDGE, a state-of-the-art Negative Pressure Wound Therapy (NPWT) system.

Designed with portability and discretion in mind, RENASYS EDGE is lightweight and compact, making it easy to carry or wear.

This launch is especially significant considering the wound care market is projected to grow to $28 billion by 2029, with chronic wounds affecting 8.2 million people in the US and incurring a healthcare cost of $33 billion.

Smith+Nephew has also announced two new national distribution partners for the RENASYS EDGE System – SunMED Medical Solutions and First Nation Group, enabling the introduction of this innovative technology to more patients on a national level and to support its growing negative pressure wound therapy business.

Chronic wounds significantly affect patients’ lives, not only causing pain and discomfort but also leading to self-consciousness and isolation for 68% of sufferers. RENASYS EDGE addresses these challenges by combining user-centric design with functionality, making it suitable for both healthcare professionals and home use.

The device’s industrial design focuses on portability and user comfort with its compact form factor allowing for easy transport, enabling patients to maintain their normal daily routines without disruption. Additionally, the device operates quietly, facilitating a peaceful environment for patients during sleep or rest.

The launch of RENASYS EDGE by Smith+Nephew is a significant step forward in enhancing the quality of life for individuals with chronic wounds. By prioritising safety, versatility, and ease of use, this device is set to transform the field of Negative Pressure Wound Therapy, improving both patient and healthcare provider experiences.